Clinical case of aplastic anemia
Regenerative biotechnologies, preventive, digital and predictive medicine · 16.06.2026 · 3 (2) · 47
DOI: 10.17116/rbpdpm2026302147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative biotechnologies, preventive, digital and predictive medicine, erschienen am 16.06.2026. Verfasst von A.G. Khrykova und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Aplastic anemia is a rare disease of the hematopoietic system characterized by suppression of all hematopoietic growths and replacement of bone marrow with fatty tissue. Annual incidence is 2—3 cases per 1 million people in Europe and America, 7—9 cases per 1 million people in East Asia. More than 300 patients with aplastic anemia were registered In Russia, and its prevalence is 0.7—4.1 per 1 million people. The highest incidence of disease occurs at the age of 10—25 years, as well as in persons older 60 years. In most cases (about 80%), etiology of disease is unknown. Acquired forms significantly predominate over congenital forms. Medications, viral infections, and other factors are possible triggers. The authors describe aplastic anemia in a young patient after previous coronavirus infection.
Zitieren
APA
Khrykova, A., Filatova, E., & Ivanova, I. (2026). Clinical case of aplastic anemia. Regenerative biotechnologies, preventive, digital and predictive medicine, 3(2), 47. https://doi.org/10.17116/rbpdpm2026302147
Vancouver
Khrykova A, Filatova E, Ivanova I. Clinical case of aplastic anemia. Regenerative biotechnologies, preventive, digital and predictive medicine. 2026;3(2):47. doi:10.17116/rbpdpm2026302147
BibTeX
@article{Khrykova2026,
author = {Khrykova, A.G. and Filatova, E.V. and Ivanova, I.I.},
title = {Clinical case of aplastic anemia},
journal = {Regenerative biotechnologies, preventive, digital and predictive medicine},
year = {2026},
volume = {3},
number = {2},
pages = {47},
doi = {10.17116/rbpdpm2026302147}
}
EUVIMED